Guard Therapeutics International AB Financial Overview
Guard Therapeutics International AB's market cap is currently kr28.23M. The company's EPS TTM is kr-1.293; its P/E ratio is -0.18; Guard Therapeutics International AB is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.